|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/551 | |
| A61K 31/423 | |||
| C07D 413/14 |
| (11) | Number of the document | 3134092 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782608.2 |
| Date of filing the European patent application | 2015-04-16 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/026060 |
| Date | 2015-04-16 |
| (87) | Number | WO 2015/164160 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 201461981889 P | 2014-04-21 | US |
| (72) |
MCNEVIN, Michael, US
LOHANI, Sachin, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST |
| PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST |